CN1247253C - Immune balancing energy restoring pill and its manufacturing method - Google Patents
Immune balancing energy restoring pill and its manufacturing method Download PDFInfo
- Publication number
- CN1247253C CN1247253C CN 200410018730 CN200410018730A CN1247253C CN 1247253 C CN1247253 C CN 1247253C CN 200410018730 CN200410018730 CN 200410018730 CN 200410018730 A CN200410018730 A CN 200410018730A CN 1247253 C CN1247253 C CN 1247253C
- Authority
- CN
- China
- Prior art keywords
- radix
- micropowder
- cancer
- medicine
- ground
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to an immune balancing and energy restoring pill a preparation method thereof. Raw medical materials of arnebia root, rhubarb, immature orange fruit, glabrous sarcandra herb, cremastra, cordrceps, magnolia bark, rhiizoma dioscorea from Hena of China, angelica and zedoray rhizome are adopted. The raw materials are divided into three groups for grinding and sifting according to proportion by weight. The three groups of the powdered medicines are fully stirred, added with medical starch, and is fully stirred. The medicine is rolled into a tablet by a flaker. The medicine quality standards of the present invention are all in accordance with the requirement of the specification in The Chinese Pharmacopoeia. Toxicity tests verify that the medicine has no obvious toxic reaction and basically has no toxicity. The present invention relates to an immune balancing and energy restoring pill, has reasonable prescription, simple preparation, pure Chinese medicines and convenient medicine taking, solve the expensive medical cost for curing cancer, and is suitable for people with different kinds of cancer and people with cancer in different stages. The forfeited life index of patients with primary liver cancer is restored, and the lives are prolonged by 17 months on average; the lives of patients with lung cancer are prolonged by 28 months on average; the lives of patients with nasopharyngeal cancer are prolonged by 28 months on average.
Description
Technical field
The present invention relates to the comprehensive treatment of cancer oral drugs of a kind of traditional Chinese medical science medicine, relate in particular to a kind of oral drugs and manufacture method of auxiliary for treating cancer.
Background technology
At present, in treatment clinical tumor process, " people-oriented " is the balance that emphasis is adjusted the tumor patient immunologic function, adjusts intravital dirty, the internal organs of human body, meridian balance.Internal organs, QI-blood circulation are rejected disease resistance, stagnation of phlegm, wet resistance, comprise vivotoxin, virus, abnormal immune complex, (in the experiment: with NO are observation index) such as inflammatory mediator, NO.Rebuild equilibrated function, meridian balance moves, QI-blood circulation is unimpeded, suppresses excessive stress state, transfers immune surveillance system identification mutant cell, strengthen the attack of T cell, K cell, NK cell, adjust the cell enhancing cycle and instruct the balance of enzyme system tumor cell.From pernicious non-controlling, the dilatancy division growth progressively recovers normal cell proliferating cycle cell.Recover physiological function.The scholar who has in the traditional Chinese medicine therapy for treatment proposes: do the basis, medication " treating the poisonous disease with poisonous drugs " as a means of essence fire " poison ".But have the scholar to think cancer person's deficient syndrome in addition, the pernicious expansion of cancer actually causes body weak, even dyscrasia.The basis of non-disease but disease be fruit.Clinically see its mark, do not study carefully it.Blindness tonify deficiency, body are difficult to digest and assimilate tonic and build up one's health by taking tonic and cause producing and life-threatening in a large number between intermedium.Below what time be the mistaken ideas of in the composite treatment pain being familiar with.The non-medication balance cause of disease, psychology, nutrition are followed card, and people-oriented.Medicine essence balance, the metabolism and the immune function of disorder in the body.
Summary of the invention
Main purpose of the present invention is to solve the problem that exists in the comprehensive cancer process of above-mentioned treatment, and a kind of oral drugs and manufacture method of auxiliary for treating cancer is provided.
The technical solution adopted for the present invention to solve the technical problems is:
Comprise that following weight proportion part crude drug makes:
Radix Arnebiae (Radix Lithospermi) 10-30 part, Radix Et Rhizoma Rhei 5-20 part, Fructus Aurantii Immaturus 3-15 part, Herba Sarcandrae 5-30 part, Pseudobulbus cremastrae seu pleiones 5-25 part, Cordyceps 5-15 part, Cortex Magnoliae Officinalis 3-10 part, Rhizoma dioscoreae 10-20 part, Radix Angelicae Sinensis 15-30 part, Rhizoma Curcumae 15-30 part, medical starch 20-30 part.
Raw material is divided into three groups by weight ratio grinds, Radix Arnebiae (Radix Lithospermi), Fructus Aurantii Immaturus, Herba Sarcandrae, Pseudobulbus Cremastrae Seu Pleiones are ground to micropowder with pulverizing mill, the process of lapping indirect is cooled to 5-10 ℃, and micropowder is the 200-240 order, sieves.
Cortex Magnoliae Officinalis, Rhizoma dioscoreae, Radix Angelicae Sinensis, Rhizoma Curcumae, Radix Et Rhizoma Rhei are ground to micropowder with pulverizing mill, and the process of lapping indirect is cooled to 5-10 ℃, and micropowder is the 200-240 order, sieves.
Cordyceps is ground to micropowder with pulverizing mill, and micropowder is the 200-240 order, and temperature is a room temperature in the process of lapping.
Three groups of medicated powder mix fully stirring, add medical starch by weight ratio, fully stir, and roll sheet with flaking machine, the packing warehouse-in.
Drug standard of the present invention is all according to " Chinese pharmacopoeia regulation requirement.
The process acute toxicity test: irritate the stomach secondary every day, administration is 50g medicated powder/kg to the maximum tolerated dose of white mice
D-1More than, be equivalent to clinical adult approximately and intend medicated powder/kg every day with metering 0.26g
D-1More than 192 times.Confirm through toxicity test, no overt toxicity reaction, nontoxic substantially.
The present invention is the oral drugs and the manufacture method of auxiliary for treating cancer.Reasonable recipe, preparation is simple, pure Chinese medicinal preparation, taking convenience.Solve the health care expenditures of treatment of cancer costliness, be applicable to the cancer crowd of various cancers crowd and disease different phase.Recover the life index: 1, pain is not used analgesic, and the patient feels hypodynia; 2, viability (eat, stop, just wait) can be autonomous, exercises the ability of life project according to independent desire; 3, a small amount of medicine of attached usefulness (before referring to art) can keep feel with life index steadily, heart rate be not higher than 100 times/minute, breathe and be not higher than 25 times/minute, speech does not have obvious pathological characters freely: dyspnea, asthma, can not feed, hydrothorax, ascites etc.; 4, general inspection is near normal, and blood red leukocyte, erythrocyte, blood glucose, BUN, creatinine etc. are near normal.
The life index that recovery has been lost to Patients with Primary prolongs average 17 months of life; The pulmonary carcinoma average life prolongs 28 months; Nasopharyngeal carcinoma life prolongs 39 months.
Improve quality of life: analgesic effect 92%, appetite recovers 78%, and gastrointestinal symptom recovers 68%, body weight gain 90%.
Solve the attack (chemotherapy, radiotherapy) of traditional treatment, compare as shown in the table with purple mountain alcohol to human tissue cell:
| Medicine | Purple mountain alcohol | The present invention |
| 1, leukocyte | Leucocytes reduction | Leukocyte is normal |
| 2, absorption mode | Injection | Oral+external (cream of drawing out pus by applying a plaster to the affected part) |
| 3, expense | The expense costliness | Be 20% of purple mountain alcohol |
| 4, treatment back effect | Treatment back recurrence interval 180 days phases of treatment | 1-2 |
| 5, Quality Of Well Being Index | General to the middle and advanced stage curative effect | Middle and advanced stage life index is obviously improved |
Below in conjunction with embodiment to the detailed description of the invention.
The specific embodiment
Embodiment 1 (high dose)
Every part of weight proportion is in 1g:
Radix Arnebiae (Radix Lithospermi) 30g, Radix Et Rhizoma Rhei 20g, Fructus Aurantii Immaturus 15g, Herba Sarcandrae 30g, Pseudobulbus cremastrae seu pleiones 25g, Cordyceps 15g, Cortex Magnoliae Officinalis 10g, Rhizoma dioscoreae 20g, Radix Angelicae Sinensis 30g, Rhizoma Curcumae 30g, medical starch 30g.
Embodiment 2 (low dosage)
Every part of weight proportion is in 1g:
Radix Arnebiae (Radix Lithospermi) 10g, Radix Et Rhizoma Rhei 5g, Fructus Aurantii Immaturus 3g, Herba Sarcandrae 5g, Pseudobulbus cremastrae seu pleiones 5g, Cordyceps 5g, Cortex Magnoliae Officinalis 3g, Rhizoma dioscoreae 10g, Radix Angelicae Sinensis 15g, Rhizoma Curcumae 15g, medical starch 20g.
Embodiment 3 (median dose)
Every part of weight proportion is in 1g:
Radix Arnebiae (Radix Lithospermi) 20g, Radix Et Rhizoma Rhei 12.5g, Fructus Aurantii Immaturus 9g, Herba Sarcandrae 17.5g, Pseudobulbus cremastrae seu pleiones 15g, Cordyceps 10g, Cortex Magnoliae Officinalis 6.5g, Rhizoma dioscoreae 15g, Radix Angelicae Sinensis 22.5g, Rhizoma Curcumae 22.5g, medical starch 25g.
Embodiment 4
Raw material is divided into three groups by weight ratio grinds, Radix Arnebiae (Radix Lithospermi), Fructus Aurantii Immaturus, Herba Sarcandrae, Pseudobulbus Cremastrae Seu Pleiones are ground to micropowder with pulverizing mill, the process of lapping indirect is cooled to 5-10 ℃, and micropowder is the 200-240 order, sieves.
Cortex Magnoliae Officinalis, Rhizoma dioscoreae, Radix Angelicae Sinensis, Rhizoma Curcumae, Radix Et Rhizoma Rhei are ground to micropowder with pulverizing mill, and the process of lapping indirect is cooled to 5-10 ℃, and micropowder is the 200-240 order, sieves.
Cordyceps is ground to micropowder with pulverizing mill, and micropowder is the 200-240 order, and temperature is a room temperature in the process of lapping.
Three groups of medicated powder mix fully stirring, add medical starch by weight ratio, fully stir, and roll sheet with flaking machine, the packing warehouse-in.
Claims (2)
1, a kind of oral drugs of auxiliary for treating cancer is characterized in that being that it is made up of the component of following weight proportion:
Radix Arnebiae (Radix Lithospermi) 10-30 part, Radix Et Rhizoma Rhei 5-20 part, Fructus Aurantii Immaturus 3-15 part, Herba Sarcandrae 5-30 part, Pseudobulbus cremastrae seu pleiones 5-25 part, Cordyceps 5-15 part, Cortex Magnoliae Officinalis 3-10 part, Rhizoma dioscoreae 10-20 part, Radix Angelicae Sinensis 15-30 part, Rhizoma Curcumae 15-30 part, medical starch 20-30 part.
2, a kind of manufacture method of oral drugs of auxiliary for treating cancer as claimed in claim 1, it is characterized in that raw material is divided into three groups by weight ratio to be ground, Radix Arnebiae (Radix Lithospermi), Fructus Aurantii Immaturus, Herba Sarcandrae, Pseudobulbus Cremastrae Seu Pleiones are ground to micropowder with pulverizing mill, the process of lapping indirect is cooled to 5-10 ℃, micropowder is the 200-240 order, sieves; Cortex Magnoliae Officinalis, Rhizoma dioscoreae, Radix Angelicae Sinensis, Rhizoma Curcumae, Radix Et Rhizoma Rhei are ground to micropowder with pulverizing mill, and the process of lapping indirect is cooled to 5-10 ℃, and micropowder is the 200-240 order, sieves; Cordyceps is ground to micropowder with pulverizing mill, and micropowder is the 200-240 order, and temperature is a room temperature in the process of lapping; Three groups of medicated powder mix fully stirring, add medical starch by weight ratio, fully stir, and roll sheet with flaking machine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410018730 CN1247253C (en) | 2004-03-10 | 2004-03-10 | Immune balancing energy restoring pill and its manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410018730 CN1247253C (en) | 2004-03-10 | 2004-03-10 | Immune balancing energy restoring pill and its manufacturing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1559545A CN1559545A (en) | 2005-01-05 |
| CN1247253C true CN1247253C (en) | 2006-03-29 |
Family
ID=34440779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410018730 Expired - Fee Related CN1247253C (en) | 2004-03-10 | 2004-03-10 | Immune balancing energy restoring pill and its manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1247253C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101632827B (en) * | 2009-08-21 | 2011-06-08 | 广州中医药大学第二临床医学院 | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof |
| CN102293877A (en) * | 2011-08-19 | 2011-12-28 | 南充市创科生物科技有限责任公司 | Chinese herbal medicine for treating nasopharyngeal carcinoma |
-
2004
- 2004-03-10 CN CN 200410018730 patent/CN1247253C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1559545A (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105920085B (en) | Composition with attenuation effect and preparation method and application thereof | |
| EP3560507B1 (en) | Traditional chinese medicine combination for regulating immune function and preparation method therefor | |
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN103155985B (en) | Rhizoma polygonati nutrition powder and preparation method thereof | |
| CN103550506B (en) | A kind of in radiotherapy with the use of Chinese medicine composition | |
| CN108524776A (en) | A kind of drug and preparation method thereof for treating Qi and Yin deficiency diabetes mellitus | |
| CN113209166A (en) | Anti-aging traditional Chinese medicine composition containing nicotinamide mononucleotide and preparation method thereof | |
| CN1247253C (en) | Immune balancing energy restoring pill and its manufacturing method | |
| CN108853350A (en) | A kind of fermented tcm formula for treating diabetes | |
| CN103989996A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN101480472B (en) | Medicament for reducing blood pressure and regulating blood fat and production method | |
| CN107158286B (en) | Traditional Chinese medicine composition for treating respiratory tract injury induced symptoms caused by haze and preparation method thereof | |
| CN1943661A (en) | A Chinese traditional medicinal composition and its preparation method | |
| CN1255158C (en) | Chinese medicine composition with action of nourishing lung, curing cough and relieving asthma | |
| CN111939223A (en) | Traditional Chinese medicine composition with auxiliary blood sugar reduction effect and preparation method thereof | |
| CN108295187A (en) | Improve the soft capsule preparation and preparation method thereof of immunity | |
| CN107823487B (en) | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and preparation method and application thereof | |
| CN1931352A (en) | Chinese medicine composition and its prepn process | |
| CN102631506B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN1575803A (en) | Application method of Aloe vera L. extract in preventing and curing diabetes | |
| CN109394968B (en) | Composition with auxiliary blood sugar reducing function and application thereof | |
| CN102631487B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102631486B (en) | Health care composition | |
| CN106309920A (en) | Traditional Chinese medicine preparation for relieving fatigue and preparation method thereof | |
| CN106177578A (en) | A kind of Chinese medicine composition of blood fat reducing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |